3 most recent filings and news items mentioning LGND. Updated every 60 seconds.
M&AJul 14, 2026Positive
Ligand Pharmaceuticals completed the acquisition of XOMA Royalty for ~$739 million, expanding its portfolio to over 200 royalty assets. The deal is expected to be immediately accretive and add exposure to major commercial products.
View filing at SEC.gov →
OfferingJun 22, 2026Neutral
Ligand Pharmaceuticals entered into a fourth amendment to its credit agreement with Citibank as administrative agent, consenting to the issuance of up to $700 million in unsecured convertible notes subject to leverage ratio compliance. The amendment provides financing flexibility
View filing at SEC.gov →
OptionsJun 17, 2026Neutral
7 Health Care Stocks With Whale Alerts In Today's Session
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.